Gastroesophageal reflux disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
446
|
52
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Renal fibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
570
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute mountain sickness
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
21
|
3
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Fibrosis, Liver
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
1179
|
64
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
ABLEPHARON-MACROSTOMIA SYNDROME
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
41
|
14
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Influenza A
|
disease |
|
Disease or Syndrome
|
563
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32
|
disease |
|
Disease or Syndrome
|
2
|
4
|
0.100 |
None |
|
0 |
2
|
|
|
Phospholipid measurement
|
phenotype |
|
Laboratory Procedure
|
58
|
306
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Fatty acid measurement
|
group |
|
Laboratory Procedure
|
50
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
0.800 |
5 |
|
2014 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.030 |
None |
1.000 |
3 |
1
|
2015 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.030 |
None |
1.000 |
3 |
1
|
2015 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2007 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2007 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2014 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Malignant neoplasm of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
949
|
103
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Choriocarcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
431
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |